Navigation Links
Statins Lower Risk of Clots in Cancer Patients
Date:10/27/2008

Study found those who took them were less likely to get venous thromboembolism

MONDAY, Oct. 27 (HealthDay News) -- A class of drugs widely used to lower cholesterol may have a future in preventing blood clots in patients with breast, lung, colon and other solid-organ cancers.

Research from scientists at the Albert Einstein Medical Center in Philadelphia found that cancer patients taking statins had a lower incidence of clots than did patients not taking the medications.

But experts cautioned that the results, which were expected to be presented at the American College of Chest Physicians' annual meeting in Philadelphia, are not yet ready for prime time.

Even the researchers noted the preliminary nature of the findings.

Study author Dr. Danai Khemasuwan called the discovery "thought-provoking," but added that randomized, controlled studies are needed before the results can be applied in the clinical arena.

Experts agreed with that analysis.

"This preliminary analysis is interesting, but far from confirmatory," said Dr. Carl "Chip" Lavie Jr., medical director of cardiac rehabilitation and prevention director of the stress testing laboratory at Ochsner Heart & Vascular Institute in New Orleans. "Statins could improve endothelial function, and this could reduce the chance of venous thrombosis. Conceivably, statins could have some benefits on clotting factors. It is known that statins can have platelet effects, but this should help arterial thrombosis and would not be expected to help venous thrombosis."

Venous thromboembolism (VTE) is a condition that includes deep vein thrombosis (DVT) as well as pulmonary embolism, or potentially fatal clots in the lung.

DVT is strongly linked to prolonged immobility, such as sitting in a plane for hours, but can strike anyone and, in fact, afflicts some 2 million Americans each year.

Statins are the class of drugs which include such well-known names as Zocor (simvastatin) and Lipitor (atorvastatin).

In addition to lowering cholesterol, researchers are looking into whether statins may lower the risk of certain types of cancer, as well as Alzheimer's.

The authors of this paper reviewed medical records for 740 patients admitted to the hospital with a diagnosis of breast, lung, colon, prostate, stomach, esophagus, pancreas, ovarian, kidney or brain cancer between October 2004 and September 2007.

Eight percent of patients who had been taking statins developed a VTE, compared with 21 percent in the control group (consisting of those individuals who had never used statins or who had only used them for less than two months).

The same results held true even after adjusting for smoking, metastatic disease, current chemotherapy, immobilization (a risk factor for DVT) and use of aspirin.

More information

The American Heart Association has more on deep vein thrombosis.



SOURCES: Carl "Chip" Lavie Jr., M.D., medical director, cardiac rehabilitation and prevention director, stress testing laboratory, Ochsner Heart & Vascular Institute, New Orleans; Danai Khemasuwan, M.D., Albert Einstein Medical Center, Philadelphia; Oct. 27, 2008, presentation, American College of Chest Physicians annual meeting, Philadelphia


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stopping Statins After Stroke Doubles Death Risk
2. Research to shed new light on how statins benefit heart patients
3. Statins reduce loss of function, keeping old lungs young - even in smokers
4. Better Prostate Cancer Survival for Men Taking Statins
5. Statins After Bypass Lower Stroke Risk
6. Latest Study Says Statins Dont Slow Alzheimers
7. New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment
8. Tendon complications, though rare, linked to statins
9. Cholesterol-Lowering Statins Tied to Tendon Woes
10. Women are treated less frequently than men with statins, aspirin and beta-blockers
11. iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins Lower Risk of Clots in Cancer Patients
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: